Patterns and problems of drug consumption in a developing country

Area of Science:

• Pharmacoeconomics
• Global Health
• Pharmaceutical Policy

Background:

• Developing countries face challenges in drug regulation, including communication gaps, lower medical standards, and inadequate monitoring systems.
• Physician prescribing habits are influenced by factors beyond clinical need, such as government-provided medications, healthcare system structures, and aggressive marketing.

Purpose of the Study:

• To analyze the multifaceted factors influencing drug consumption phases in developing nations.
• To investigate the dynamics of new drug adoption and the displacement of established medications.

Main Methods:

• The study involved a survey of drug consumption patterns, including the phenomenon of "home pharmacies."
• Analysis of prescription data and influencing factors such as government subsidies and marketing strategies.

Main Results:

• Drug categories consumed are broadly similar to Europe, the US, and Latin America.
• Significant shifts in drug usage were observed: meprobamate and chlordiazepoxide consumption increased, while phenobarbital remained stable. Rauwolfia usage declined, with a >200% increase in methyldopa.
• Overall drug consumption, particularly minor tranquilizers, rose by 72.1% in Hungary between 1969-1973.

Conclusions:

• Drug consumption in developing countries is a complex interplay of systemic deficiencies, external influences, and market dynamics.
• The observed trends illustrate a typical pattern of new drug introduction and the subsequent displacement of older drugs.
• Effective drug management requires addressing regulatory, economic, and marketing factors to ensure appropriate medication use.